ArticleFrontiers in immunology2020

Low-Dose Gemcitabine Treatment Enhances Immunogenicity and Natural Killer Cell-Driven Tumor Immunity in Lung Cancer.

Xin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.